Story perspectives

CEO Urges Kennedy to Avoid Tylenol-Autism Claims Amid Stock Plunge

9/13/2025

27 5

Summary

Story summary

Kenvue's CEO, Kirk Perry, requested Robert F. Kennedy Jr. not to link Tylenol to autism risks during a meeting.
Kennedy's agency plans to publish a report connecting acetaminophen use in pregnancy to autism, despite no scientific consensus.
Kenvue's stock fell over 9% after news of the report emerged.
The U.S. Department of Health and Human Services called any claims about the report speculative until its release.
Kenvue asserts that acetaminophen is safe for pregnant women, despite ongoing lawsuits.

1 of 1

Story summary

Kenvue's CEO, Kirk Perry, requested Robert F. Kennedy Jr. not to link Tylenol to autism risks during a meeting.
Kennedy's agency plans to publish a report connecting acetaminophen use in pregnancy to autism, despite no scientific consensus.
Kenvue's stock fell over 9% after news of the report emerged.
The U.S. Department of Health and Human Services called any claims about the report speculative until its release.
Kenvue asserts that acetaminophen is safe for pregnant women, despite ongoing lawsuits.